Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2021

 

Upgrades

  • For Alcoa Corp AA, Argus Research upgraded the previous rating of Hold to Buy. Alcoa earned $1.49 in the second quarter, compared to $0.02 in the year-ago quarter. The stock has a 52-week-high of $51.17 and a 52-week-low of $10.98. At the end of the last trading period, Alcoa closed at $48.00.
  • According to Cowen & Co., the prior rating for Knight-Swift Transportation Holdings Inc KNX was changed from Market Perform to Outperform. For the second quarter, Knight-Swift had an EPS of $0.98, compared to year-ago quarter EPS of $0.57. The current stock performance of Knight-Swift shows a 52-week-high of $54.00 and a 52-week-low of $37.07. Moreover, at the end of the last trading period, the closing price was at $51.72.
  • JP Morgan upgraded the previous rating for SM Energy Co SM from Neutral to Overweight. In the second quarter, SM Energy showed an EPS of $0.01, compared to $0.15 from the year-ago quarter. The stock has a 52-week-high of $26.86 and a 52-week-low of $1.34. At the end of the last trading period, SM Energy closed at $20.26.
  • JP Morgan upgraded the previous rating for Range Resources Corp RRC from Underweight to Neutral. For the second quarter, Range Resources had an EPS of $0.24, compared to year-ago quarter EPS of $0.10. The stock has a 52-week-high of $18.82 and a 52-week-low of $5.93. At the end of the last trading period, Range Resources closed at $18.39.
  • According to Guggenheim, the prior rating for Sarepta Therapeutics Inc SRPT was changed from Neutral to Buy. For the second quarter, Sarepta Therapeutics had an EPS of $1.52, compared to year-ago quarter EPS of $1.51. The current stock performance of Sarepta Therapeutics shows a 52-week-high of $181.83 and a 52-week-low of $65.30. Moreover, at the end of the last trading period, the closing price was at $80.28.
  • For Schneider National Inc SNDR, Cowen & Co. upgraded the previous rating of Market Perform to Outperform. In the second quarter, Schneider National showed an EPS of $0.60, compared to $0.26 from the year-ago quarter. The current stock performance of Schneider National shows a 52-week-high of $27.15 and a 52-week-low of $20.20. Moreover, at the end of the last trading period, the closing price was at $21.98.
  • According to Cowen & Co., the prior rating for Werner Enterprises Inc WERN was changed from Market Perform to Outperform. Werner Enterprises earned $0.86 in the second quarter, compared to $0.62 in the year-ago quarter. At the moment, the stock has a 52-week-high of $49.76 and a 52-week-low of $35.15. Werner Enterprises closed at $45.96 at the end of the last trading period.

See all analyst ratings upgrades.

 

Downgrades

  • For Southwestern Energy Co SWN, JP Morgan downgraded the previous rating of Neutral to Underweight. Southwestern Energy earned $0.19 in the second quarter, compared to $0.00 in the year-ago quarter. The current stock performance of Southwestern Energy shows a 52-week-high of $5.85 and a 52-week-low of $2.18. Moreover, at the end of the last trading period, the closing price was at $5.16.
  • According to JP Morgan, the prior rating for Chevron Corp CVX was changed from Overweight to Neutral. For the second quarter, Chevron had an EPS of $1.71, compared to year-ago quarter EPS of $1.59. At the moment, the stock has a 52-week-high of $113.11 and a 52-week-low of $65.16. Chevron closed at $96.20 at the end of the last trading period.
  • Ladenburg Thalmann downgraded the previous rating for Itamar Medical Ltd ITMR from Buy to Neutral. For the second quarter, Itamar Medical had an EPS of $0.20, compared to year-ago quarter EPS of $0.17. The current stock performance of Itamar Medical shows a 52-week-high of $30.40 and a 52-week-low of $16.36. Moreover, at the end of the last trading period, the closing price was at $30.40.
  • According to BTIG, the prior rating for Integra Lifesciences Holdings Corp IART was changed from Buy to Neutral. In the second quarter, Integra Lifesciences showed an EPS of $0.79, compared to $0.33 from the year-ago quarter. At the moment, the stock has a 52-week-high of $77.40 and a 52-week-low of $42.12. Integra Lifesciences closed at $69.95 at the end of the last trading period.

See all analyst ratings downgrades.

 

Initiations

  • With an Outperform rating, Northland Capital Markets initiated coverage on Motion Acquisition Corp MOTN. The price target seems to have been set at $16.00 for Motion Acquisition. At the moment, the stock has a 52-week-high of $11.75 and a 52-week-low of $9.77. Motion Acquisition closed at $9.95 at the end of the last trading period.
  • With a Buy rating, Maxim Group initiated coverage on Unisys Corp UIS. The price target seems to have been set at $35.00 for Unisys. Unisys earned $0.68 in the second quarter, compared to $0.15 in the year-ago quarter. At the moment, the stock has a 52-week-high of $28.60 and a 52-week-low of $10.12. Unisys closed at $23.30 at the end of the last trading period.
  • Maxim Group initiated coverage on 180 Life Sciences Corp ATNF with a Buy rating. The price target for 180 Life Sciences is set to $11.00. In the second quarter, 180 Life Sciences earned $0.75. The current stock performance of 180 Life Sciences shows a 52-week-high of $13.05 and a 52-week-low of $1.90. Moreover, at the end of the last trading period, the closing price was at $5.67.
  • Guggenheim initiated coverage on Surrozen Inc SRZN with a Buy rating. The price target for Surrozen is set to $20.00. At the end of the last trading period, Surrozen closed at $10.13.
  • With a Neutral rating, Citigroup initiated coverage on EVgo Inc EVGO. The price target seems to have been set at $10.00 for EVgo. In the second quarter, EVgo earned $4.49. At the moment, the stock has a 52-week-high of $16.24 and a 52-week-low of $7.90. EVgo closed at $7.99 at the end of the last trading period.
  • With a Neutral rating, Citigroup initiated coverage on CCC Intelligent Solutions Holdings Inc CCCS. The price target seems to have been set at $13.00 for CCC Intelligent Solutions. At the end of the last trading period, CCC Intelligent Solutions closed at $11.29.
  • BTIG initiated coverage on Sonnet BioTherapeutics Holdings Inc SONN with a Buy rating. The price target for Sonnet BioTherapeutics is set to $5.00. In the third quarter, Sonnet BioTherapeutics showed an EPS of $0.27, compared to $0.44 from the year-ago quarter. At the moment, the stock has a 52-week-high of $3.42 and a 52-week-low of $0.55. Sonnet BioTherapeutics closed at $0.56 at the end of the last trading period.
  • B of A Securities initiated coverage on Lucid Group Inc LCID with a Buy rating. The price target for Lucid Gr is set to $30.00. Moreover, at the end of the last trading period, the closing price was at $18.95.
  • Cantor Fitzgerald initiated coverage on Equillium Inc EQ with an Overweight rating. The price target for Equillium is set to $14.00. Equillium earned $0.31 in the second quarter, compared to $0.37 in the year-ago quarter. The stock has a 52-week-high of $11.33 and a 52-week-low of $3.47. At the end of the last trading period, Equillium closed at $5.40.
  • Wells Fargo initiated coverage on Wynn Resorts Ltd WYNN with a Equal-Weight rating. The price target for Wynn Resorts is set to $112.00. Wynn Resorts earned $1.12 in the second quarter, compared to $6.14 in the year-ago quarter. The stock has a 52-week-high of $143.88 and a 52-week-low of $67.70. At the end of the last trading period, Wynn Resorts closed at $92.25.
  • With a Equal-Weight rating, Wells Fargo initiated coverage on Las Vegas Sands Corp LVS. The price target seems to have been set at $50.00 for Las Vegas Sands. In the second quarter, Las Vegas Sands showed an EPS of $0.26, compared to $1.05 from the year-ago quarter. The stock has a 52-week-high of $66.77 and a 52-week-low of $36.42. At the end of the last trading period, Las Vegas Sands closed at $38.71.
  • With an Overweight rating, Wells Fargo initiated coverage on Caesars Entertainment Inc CZR. The price target seems to have been set at $137.00 for Caesars Entertainment. In the second quarter, Caesars Entertainment showed an EPS of $0.59, compared to $1.25 from the year-ago quarter. At the moment, the stock has a 52-week-high of $113.46 and a 52-week-low of $43.07. Caesars Entertainment closed at $103.07 at the end of the last trading period.
  • Mizuho initiated coverage on SoFi Technologies Inc SOFI with a Buy rating. The price target for SoFi Technologies is set to $28.00. For the second quarter, SoFi Technologies had an EPS of $0.48, compared to year-ago quarter EPS of $0.03. At the moment, the stock has a 52-week-high of $24.95 and a 52-week-low of $13.56. SoFi Technologies closed at $14.50 at the end of the last trading period.

See all analyst ratings initiations.

Posted In: BZI-RatingsUpgradesDowngradesInitiationIntraday UpdateAnalyst Ratings

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.